The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis
Author:
Funder
National Health and Medicine Research Council
Cancer Institute New South Wales
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/6/1308/577331/mdq593.pdf
Reference44 articles.
1. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women;Fossati;J Clin Oncol,1998
2. A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer;De Laurentiis;Clin Cancer Res,2005
3. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers—a review;Ravdin;Gene,1995
4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
5. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond;Journal of Internal Medicine;2024-05-02
2. Systemic Treatment of Metastatic Breast Cancer in Older Adults;Geriatric Oncology;2020
3. Diarrhea With HER2-Targeted Agents in Cancer Patients: A Systematic Review and Meta-Analysis;The Journal of Clinical Pharmacology;2019-02-01
4. AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice;World Allergy Organization Journal;2019
5. Anti-neoplastic cytotoxicity by complementary simultaneous selective “targeted” delivery for pulmonary adenocarcinoma: fludarabine-(5′-phosphoramidate)-[anti-IGF-1R] in dual-combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR];Journal of Pharmaceutical Investigation;2018-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3